Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluating the Retinal and Choroidal Microvasculature and Structure Using Multimodal Retinal and Choroidal Imaging in Neurodegenerative Disease: iMIND Research Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03233646
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:29.813874+00:00
Published At
2026-02-04T00:00:00+00:00
Record Updated At
2026-02-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Alzheimer\u0027s Disease", "Mild Cognitive Impairment", "Parkinson\u0027s Disease", "Multiple Sclerosis", "Huntington Disease", "Lewy Body Dementia", "Frontotemporal Dementia", "Amyotrophic Lateral Sclerosis (ALS)", "APOE-4 Positive", "Traumatic Brain Injury", "Concussion", "Post-Traumatic Stress Disorder", "Down Syndrome", "Neuro-Degenerative Disease", "Normal Cognition"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-04"
protocolSection.identificationModule.nctId
"NCT03233646"
protocolSection.identificationModule.officialTitle
"Evaluating the Retinal and Choroidal Microvasculature and Structure Using Multimodal Retinal and Choroidal Imaging in Neurodegenerative Disease: iMIND Research Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Alzheimer's Disease (protocolSection.conditionsModule.conditions)
  • Mild Cognitive Impairment (protocolSection.conditionsModule.conditions)
  • Parkinson's Disease (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Huntington Disease (protocolSection.conditionsModule.conditions)
  • Lewy Body Dementia (protocolSection.conditionsModule.conditions)
  • Frontotemporal Dementia (protocolSection.conditionsModule.conditions)
  • Amyotrophic Lateral Sclerosis (ALS) (protocolSection.conditionsModule.conditions)
  • APOE-4 Positive (protocolSection.conditionsModule.conditions)
  • Traumatic Brain Injury (protocolSection.conditionsModule.conditions)
  • Concussion (protocolSection.conditionsModule.conditions)
  • Post-Traumatic Stress Disorder (protocolSection.conditionsModule.conditions)
  • Down Syndrome (protocolSection.conditionsModule.conditions)
  • Neuro-Degenerative Disease (protocolSection.conditionsModule.conditions)
  • Normal Cognition (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.